基因组增益/甲基化修饰/hsa-miR-132-3p增加RRS1过度表达在肝肝细胞癌
Xiaoxia Zhang1, Peilin Cong2,3,4,5, Li Tian2,3,4,5
1Department of Hospital Infection Management, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Cancer science
|September 14, 2023
概括
核糖体生物发生调节器1同源 (RRS1) 在许多癌症中升高,特别是肝肝细胞癌 (LIHC),并预测预后不佳. 针对RRS1及其调节器hsa-miR-132-3p可能提供新的LIHC疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 核糖体生物发生调节器1同源 (RRS1) 涉及到细胞过程.
- 它在肝肝细胞癌 (LIHC) 发展和预后中的作用需要进一步阐明.
研究的目的:
- 调查LIHC中RRS1表达的上游调控因素.
- 评估RRS1与LIHC预后,免疫格局和治疗反应的关联.
主要方法:
- 在泛癌和LIHC数据集中分析RRS1表达.
- 与生存,免疫透和免疫检查点的相关性分析.
- 使用细胞系进行体外验证,包括hsa-miR-132-3p敲击和功能测试.
主要成果:
- 在27种癌症中,RRS1被上调,并与LIHC和其他癌症的预后不佳有关.
- 在LIHC中,RRS1表达与免疫细胞透和免疫检查点基因相关.
- 低RRS1促进子甲基化,RRS1基因组增益和高hsa-miR-132-3p有助于RRS1上调和LIHC预后不佳.
结论:
- RRS1是一种潜在的预后生物标志物和LIHC的治疗点.
- 在LIHC发育过程中,Hsa-miR-132-3p作为RRS1的瘤调节剂.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


